Journal
LANCET NEUROLOGY
Volume 3, Issue 6, Pages 362-368Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(04)00769-0
Keywords
-
Categories
Ask authors/readers for more resources
Several separate gene mutations have now been identified in familial Parkinson's disease and important environmental influences modulating risk for the idiopathic form of the disease have also been recognised. These insights have provided important clues in the development of disease modifying therapies. Some compounds have already been shown to potentially delay disease progression in early clinical trials. The most important challenge, particularly for those drugs that might have a symptomatic effect, is defining appropriate markers that will confirm a neuroprotective effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available